Early empirical antibiotherapy in patients attended for suspected sepsis in emergency departments: a systematic review
- PMID: 39898946
- DOI: 10.55633/s3me/092.2024
Early empirical antibiotherapy in patients attended for suspected sepsis in emergency departments: a systematic review
Abstract
Objective: Patients with suspected infections account for 15% to 35% of hospital emergency department (ED) caseloads in Spain and Latin America. The main objective of this systematic review was to compare evidence supporting the safety and efficacy of early (3 hours after triage) vs deferred ($ 3-6 hours) antibiotic therapy prescribed in EDs for adults with serious infections or sepsis. Efficacy and improved clinical course were defined by reduced progression to septic shock and short- and long-term mortality.
Methods: The review was guided by the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA). PubMed, the Web of Sciencie, EMBASE, Lilacs, Cochrane, Epistemonikos, Tripdatabase, and ClinicalTrials.gov were searched for the period from January 1, 2010, to December 31, 2023. No language restrictions were set. We used the following Medical English Subject Headings and strings: "Antibiotic OR Antibiotic Treatment OR Antibiotic Therapy OR Early Antibiotic Treatment OR Early Antibiotic Therapy," "Infection OR Bacterial Infection OR Sepsis," "Emergencies OR Emergency OR Emergency Department," "Timing," "Early," and "Adults." Observational cohort studies were included. To evaluate quality of research design and risk of bias, we applied the Newcastle-Ottawa Scale. Case-control studies, narrative reviews and other types of articles were excluded. We completed a narrative review of the findings and did not undertake meta-analysis. The review was registered in the PROSPERO database (CRD42024520687).
Results: The search yielded 1528 articles, of which 7 met the criteria for inclusion and analysis. The 7 studies comprised data for 118349 patients, 74141 of whom (62.6%) received early antibiotic treatment. Three studies were classified as high quality, 3 moderate, and 1 low. The 3 high-quality studies provided information on 2 aspects: 1) hospital and short-term mortality and 2) long-term mortality. One high-quality study showed a tendency for hospital and 30-day mortality to increase when antibiotics were administered more than 6 hours after triage vs within 1 hour of triage (hazard ratio, 2.25; 95% CI, 0.91-5.59; P = .08). Another reported an adjusted odds ratio of 1.09 (95% CI, 1.05-1.13; P = .024) for hospital mortality associated with each hour of therapeutic delay after triage. The third study reported that each additional hour of delay after triage was associated with a 10% increase (95% CI, 5%-14%; P .001) in the probability of 360-day mortality. Finally, the single low-quality study reported that each hour of delay in treatment was associated with an odds ratio of 1.08 (95% CI, 1.02-1.04; P .001) for increased risk of septic shock.
Conclusions: Early initiation of antibiotic therapy, preferably within 3 hours of triage, can be recommended in cases of serious infection (sepsis or serious sepsis that do not meet the criteria for septic shock). In fact, based on a tendency for higher short- and long-term mortality associated with delay and a higher probability of developing septic shock with each hour of delay, therapy should start as soon as possible if infection is confirmed or suspected in the absence of an alternative diagnosis.
Objetivo: La atención de pacientes con sospecha de un proceso infeccioso en los servicios de urgencias hospitalarios (SUH) supone el 15%-35% de todas las atenciones en España y Latinoamérica. Esta revisión sistemática (RS) compara si la administración precoz de la antibioterapia (en 3 horas desde que el paciente se recibe en el triaje) en pacientes adultos atendidos en los SUH por infección grave o sepsis, en comparación con la administración diferida (> 3-6 horas), es más eficaz y segura y mejora la evolución clínica al disminuir la progresión a shock séptico (SS) y la mortalidad a corto y largo plazo.
Metodo: Se realiza una RS siguiendo la normativa PRISMA en las bases de datos de PubMed, Web of Sciencie, EMBASE, Lilacs, Cochrane, Epistemonikos, Tripdatabase y ClinicalTrials.gov desde desde 1 de enero de 2010 hasta el 31 de diciembre de 2023 sin restricción de idiomas y utilizando una combinación de términos MESH: “Antibiotic OR Antibiotic Treatment OR Antibiotic Therapy OR Early Antibiotic Treatment OR Early Antibiotic Therapy”, “Infection OR Bacterial Infection OR Sepsis”, “Emergencies OR Emergency OR Emergency Department”, “Timing”, “Early” y “Adults”. Se incluyeron estudios de cohortes observacionales. Para valorar la calidad del método empleado y el riesgo de sesgos de los artículos incluidos se utilizó la Newcastle-Ottawa Scale (NOS). No se incluyeron estudios de casos y controles, revisiones narrativas y otros tipos de artículos. No se realizaron técnicas de metanálisis, pero los resultados se compararon narrativamente. El protocolo de la RS se registró en PROSPERO (CRD42024520687).
Resultados: Se identificaron 1.528 artículos de los cuales se analizaron finalmente 7, que incluyen 118.349 pacientes, 74.141 de ellos (62,6%) con administración precoz de antibiótico (AB). Tres estudios fueron calificados de calidad alta, 3 moderada y 1 baja. En relación a los resultados de los estudios de calidad alta se encontró lo siguiente: 1) con la mortalidad hospitalaria y a corto plazo (30 días) en función del tiempo de administración del AB desde el triaje y la gravedad de la sepsis: el primer estudio de calidad alta publica una tendencia a aumentar la mortalidad cuando se administró el AB en > 6 horas desde el triaje en comparación con administración en 1 hora (HR = 2,25; IC 95%: 0,91-5,59; p = 0,08); el segundo muestra una OR ajustada para mortalidad hospitalaria por cada hora de tiempo de administración del AB desde el triaje de 1,09 (IC 95%: 1,05-1,13; p = 0,024); 2) con la mortalidad a largo plazo el tercer estudio muestra como cada hora adicional hasta el inicio del AB se asocia con un aumento del 10% (IC 95%: 5-14; p 0,001) de probabilidad de morir a los 360 días. Finalmente, un estudio de calidad baja muestra como el tiempo (en horas) hasta la primera administración del AB obtiene una OR de 1,03 (IC 95%: 1,02-1,04; p 0,001) para la progresión al SS.
Conclusiones: En los casos de infección grave (sepsis o sepsis grave) sin cumplir criterios de SS, se puede recomendar la administración precoz de la terapia antimicrobiana preferiblemente en las tres primeras horas (en realidad lo antes posible, en cuanto se pueda confirmar o se mantenga la sospecha sin encontrar otro diagnóstico distinto), ya que se ha confirmado la tendencia a aumentar la mortalidad a corto y a largo plazo y una mayor probabilidad de evolucionar a SS cuando se demora la administración del AB cada hora.
Keywords: Antibioterapia; Antibiotics; Bacterial infections; Emergency health services; Infección bacteriana; Sepsis; Servicios de Urgencias.
Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
[Early source control of infection in patients seen in the emergency department: a systematic review].Rev Esp Quimioter. 2024 Aug;37(4):323-333. doi: 10.37201/req/027.2024. Epub 2024 May 14. Rev Esp Quimioter. 2024. PMID: 38742536 Free PMC article. Spanish.
-
Antibiotic Delays and Feasibility of a 1-Hour-From-Triage Antibiotic Requirement: Analysis of an Emergency Department Sepsis Quality Improvement Database.Ann Emerg Med. 2020 Jan;75(1):93-99. doi: 10.1016/j.annemergmed.2019.07.017. Epub 2019 Sep 24. Ann Emerg Med. 2020. PMID: 31561998
-
Models to predict bacteremia in the emergency department: a systematic review.Emergencias. 2024 Jan;36(1):48-62. doi: 10.55633/s3me/06.2023. Emergencias. 2024. PMID: 38318742 English, Spanish.
-
Antibiotic Timing and Progression to Septic Shock Among Patients in the ED With Suspected Infection.Chest. 2022 Jan;161(1):112-120. doi: 10.1016/j.chest.2021.06.029. Epub 2021 Jun 26. Chest. 2022. PMID: 34186038
Cited by
-
[Ability of midregional proadrenomedullin (MR-proADM) to predict poor clinical outcome and stratify prognosis in adult patients seen for suspected infection in the Emergency Department].Rev Esp Quimioter. 2025 May 27;38(4):319-334. doi: 10.37201/req/031.2025. Epub 2025 May 27. Rev Esp Quimioter. 2025. PMID: 40432452 Free PMC article. Spanish.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous